An update on trigger point injection in the management of chronic musculoskeletal conditions: From research to practice

Title : An update on trigger point injection in the management of chronic musculoskeletal conditions: From research to practice

Abstract:

Myofascial Trigger Point (MTrP) may be considered as a common consequence of chronic musculoskeletal disorders. There are multiple treatment options for the management of MTrP including conservative treatment strategies and invasive therapeutic protocols. From these, Trigger Point Injection (TPI) is a widely used aggressive therapy wherein a needle is guided directly into a MTrP. However, TPI is best used as part of a comprehensive multimodal treatment plan. This strategy can be particularly effective when TPI is primarily used to diminish pain in patients otherwise intolerant of physical therapy or stretching, allowing the physical modalities to be more effective. The aim of this presentation is to review the benefits, mechanisms, and the studies focusing on TPI.  

Biography:

Vahid Mazloum is a physiotherapist and academic researcher with many years of clinical experience. Due to his keen interest in the field of sports medicine, he continued his postgraduate studies in this field and successfully obtained his PhD in 2016. He has conducted most of his studies in the field of sports and musculoskeletal rehabilitation, which has resulted in the publication of several domestic and international articles. Dr. Mazloum has taught courses related to sports rehabilitation in many universities and works as a workshop instructor. The workshops’ topics include Dry Needling, Positional Release Therapy, Therapeutic Exercise in Musculoskeletal Disorders.